Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORT...
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
This study aimed to investigate whether molecular analysis can be used to refine risk assessment, direct adjuvant therapy, and identify actionable alterations in high-risk endometrial cancer.
Trans
PORTEC, an international consortium related to the PORTEC3 trial, was established for translational research in high-risk endometrial cancer. In t...
Alternative Titles
Full title
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1683979786
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1683979786
Other Identifiers
ISSN
0893-3952
E-ISSN
1530-0285
DOI
10.1038/modpathol.2015.43
